Zr-labeled N4MU01 radioimmunoconjugates as theranostics against nectin-4 positive triple negative breast cancer
H. Babeker, F. N. Njotu, J. P. Ketchemen, A. F. Tikum, A. Doroudi, E. Nwangele, M. Uppalapati, H. Fonge
This study develops and evaluates Zr-labeled N4MU01 radioimmunoconjugates for imaging and radiotherapy of nectin-4 positive triple-negative breast cancer, showing promising tumor uptake and therapeutic efficacy.
bioRxiv · Mar 4, 2024Pharmacology & Toxicology